Dexcom (DXCM) Raw Materials (2010 - 2026)

Dexcom (DXCM) has reported Raw Materials for 13 consecutive years, with $232.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Raw Materials fell 32.77% year-over-year to $232.7 million in Q2 2026; TTM through Jun 2026 was $232.7 million, a 32.77% decrease from a year earlier, with the FY2025 full-year figure at $257.6 million, down 21.25% from the prior year.
• Raw Materials was $232.7 million for Q2 2026 at Dexcom, down from $247.9 million in the prior quarter.
• Over five years, Raw Materials peaked at $366.0 million in Q1 2025 and troughed at $151.1 million in Q2 2022.
• A 5-year average of $252.8 million and a median of $253.0 million in 2024 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials surged 100.94% in 2023 and sank 32.77% in 2026, its largest moves.
• Over 5 years, Raw Materials stood at $159.0 million in 2022, then surged by 100.94% to $319.5 million in 2023, then rose by 2.38% to $327.1 million in 2024, then decreased by 21.25% to $257.6 million in 2025, then fell by 9.67% to $232.7 million in 2026.
• The last three Raw Materials figures came in at $232.7 million (Q2 2026), $247.9 million (Q1 2026), and $257.6 million (Q4 2025), per Business Quant data.